133 related articles for article (PubMed ID: 15683746)
1. Chloroquine induces the expression of inducible nitric oxide synthase in C6 glioma cells.
Chen TH; Chang PC; Chang MC; Lin YF; Lee HM
Pharmacol Res; 2005 Apr; 51(4):329-36. PubMed ID: 15683746
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycosylation end products induce nitric oxide synthase expression in C6 glioma cells: involvement of a p38 MAP kinase-dependent mechanism.
Lin CH; Lin YF; Chang MC; Wu CH; Ho YS; Lee HM
Life Sci; 2001 Oct; 69(21):2503-15. PubMed ID: 11693258
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway.
Chang PC; Chen TH; Chang CJ; Hou CC; Chan P; Lee HM
Kidney Int; 2004 May; 65(5):1664-75. PubMed ID: 15086905
[TBL] [Abstract][Full Text] [Related]
4. P38 MAPK, but not p42/p44 MAPK mediated inducible nitric oxide synthase expression in C6 glioma cells.
Xu X; Malave A
Life Sci; 2000 Nov; 67(26):3221-30. PubMed ID: 11191629
[TBL] [Abstract][Full Text] [Related]
5. Forskolin inhibits expression of inducible nitric oxide synthase mRNA via inhibiting the mitogen activated protein kinase in C6 cells.
Won JS; Lee JK; Suh HW
Brain Res Mol Brain Res; 2001 Apr; 89(1-2):1-10. PubMed ID: 11311970
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide plus 12-o-tetradecanoylphorbol 13-acetate induction of migration and invasion of glioma cells in vitro and in vivo: Differential inhibitory effects of flavonoids.
Shen SC; Lin CW; Lee HM; Chien LL; Chen YC
Neuroscience; 2006 Jun; 140(2):477-89. PubMed ID: 16580779
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms underlying dexamethasone inhibition of iNOS expression and activity in C6 glioma cells.
Shinoda J; McLaughlin KE; Bell HS; Swaroop GR; Yamaguchi S; Holmes MC; Whittle IR
Glia; 2003 Apr; 42(1):68-76. PubMed ID: 12594738
[TBL] [Abstract][Full Text] [Related]
8. P38 mitogen-activated protein kinase inhibitor SB203580 has a bi-directional effect on iNOS expression and NO production.
Lahti A; Kankaanranta H; Moilanen E
Eur J Pharmacol; 2002 Nov; 454(2-3):115-23. PubMed ID: 12421638
[TBL] [Abstract][Full Text] [Related]
9. IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways.
Kim YJ; Hwang SY; Oh ES; Oh S; Han IO
J Neurosci Res; 2006 Oct; 84(5):1037-46. PubMed ID: 16881054
[TBL] [Abstract][Full Text] [Related]
10. c-Jun N-terminal kinase and p38 mitogen-activated protein kinase mediate double-strand RNA-induced inducible nitric oxide synthase expression in microglial cells.
Kong PJ; Lee HJ; Lee SH; Kim SY; Lee SN; Chun WJ; Kim SS
Neurosci Lett; 2008 Mar; 433(3):215-8. PubMed ID: 18258363
[TBL] [Abstract][Full Text] [Related]
11. Suppression of iNOS expression by fucoidan is mediated by regulation of p38 MAPK, JAK/STAT, AP-1 and IRF-1, and depends on up-regulation of scavenger receptor B1 expression in TNF-alpha- and IFN-gamma-stimulated C6 glioma cells.
Do H; Pyo S; Sohn EH
J Nutr Biochem; 2010 Aug; 21(8):671-9. PubMed ID: 19576750
[TBL] [Abstract][Full Text] [Related]
12. Antisense oligonucleotides targeting protein kinase C-alpha, -beta I, or -delta but not -eta inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear factor kappa B-dependent mechanism.
Chen CC; Wang JK; Lin SB
J Immunol; 1998 Dec; 161(11):6206-14. PubMed ID: 9834107
[TBL] [Abstract][Full Text] [Related]
13. Lipoteichoic acid-induced nitric oxide synthase expression in RAW 264.7 macrophages is mediated by cyclooxygenase-2, prostaglandin E2, protein kinase A, p38 MAPK, and nuclear factor-kappaB pathways.
Chang YC; Li PC; Chen BC; Chang MS; Wang JL; Chiu WT; Lin CH
Cell Signal; 2006 Aug; 18(8):1235-43. PubMed ID: 16289764
[TBL] [Abstract][Full Text] [Related]
14. Role of p38 mitogen-activated protein kinase in lipopolysaccharide-induced expression of inducible nitric oxide synthase in human endothelial cells.
Kan WH; Yan WS; Jiang Y; Wang JZ; Qin QH; Zhao KS
Di Yi Jun Yi Da Xue Xue Bao; 2002 May; 22(5):388-92. PubMed ID: 12390692
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide enhancement of 12-o-tetradecanoylphorbol 13-acetate-mediated transformation in rat glioma C6, accompanied by induction of inducible nitric oxide synthase.
Chen TJ; Shen SC; Lin HY; Chien LL; Chen YC
Toxicol Lett; 2004 Feb; 147(1):1-13. PubMed ID: 14700523
[TBL] [Abstract][Full Text] [Related]
16. Docosahexaenoic acid potentiates interleukin-1beta induction of nitric oxide synthase through mechanism involving p44/42 MAPK activation in rat vascular smooth muscle cells.
Hirafuji M; Machida T; Tsunoda M; Miyamoto A; Minami M
Br J Pharmacol; 2002 Jun; 136(4):613-9. PubMed ID: 12055140
[TBL] [Abstract][Full Text] [Related]
17. TAK1-mediated induction of nitric oxide synthase gene expression in glial cells.
Bhat NR; Shen Q; Fan F
J Neurochem; 2003 Oct; 87(1):238-47. PubMed ID: 12969270
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of p38 mitogen-activated protein kinase enhances c-Jun N-terminal kinase activity: implication in inducible nitric oxide synthase expression.
Lahti A; Sareila O; Kankaanranta H; Moilanen E
BMC Pharmacol; 2006 Feb; 6():5. PubMed ID: 16504051
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
[TBL] [Abstract][Full Text] [Related]
20. Effect of N-nitrosodimethylamine on inducible nitric oxide synthase expression and production of nitric oxide by neutrophils and mononuclear cells: the role of JNK signalling pathway.
Ratajczak-Wrona W; Jablonska E; Garley M; Jablonski J; Radziwon P
APMIS; 2011 Jul; 119(7):431-41. PubMed ID: 21635550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
